Clinical Trials for Metastatic Prostate Adenocarcinoma

Find clinical trials for metastatic prostate adenocarcinoma. Discover research opportunities and treatment options in your area.

16 Active Trials Found

Showing 16 trials on this page

Page 1 of 1

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

NCT ID: NCT06982222

This clinical trial is testing a new anti-cancer drug called Sn-117m-DTPA to see if it is safe and effective for patients with advanced cancers that have spread to the bones, such as prostate, brea...

Not yet recruiting

Phase: PHASE1 Type: interventional

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT ID: NCT04704505

This clinical trial is studying the combination of two treatments—Bipolar Androgen Therapy (BAT) and Radium-223 (RAD)—for men with a specific type of prostate cancer called metastatic castration-re...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States, Porto Alegre, , Brazil

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

NCT ID: NCT05113537

This clinical trial is studying a new treatment approach for men with advanced prostate cancer that has spread to other parts of the body and is no longer responding to standard hormone therapy. Th...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Francisco, California, United States

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

NCT ID: NCT06616155

This clinical trial is studying a combination of two medications, ruxolitinib and enzalutamide, to see if they can be safe and effective for treating advanced prostate cancer that continues to grow...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, Chicago, Illinois, United States +1 more

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

NCT ID: NCT06039371

The SPECTRA Study is a clinical trial designed to explore whether giving higher levels of testosterone can help improve the effects of chemotherapy in men with advanced prostate cancer that has con...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

NCT ID: NCT04471974

This clinical trial, titled ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, is exploring how effective a combination of three treatme...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ann Arbor, Michigan, United States, San Francisco, California, United States +1 more

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

NCT ID: NCT05168618

The AtezoCab Trial is a clinical study investigating the effectiveness of two drugs, cabozantinib and atezolizumab, in treating men with advanced prostate cancer that has continued to grow despite ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Salt Lake City, Utah, United States

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

NCT ID: NCT06931340

The ASPIRE Trial is a clinical study designed to find out if adding a chemotherapy drug called docetaxel to standard treatments for metastatic prostate cancer can improve patient outcomes. In this ...

Not yet recruiting

Phase: PHASE3 Type: interventional

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

NCT ID: NCT06236139

This clinical trial is exploring a new treatment option for men with advanced prostate cancer that continues to grow despite previous treatments. The study is testing a combination of two therapies...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

NCT ID: NCT06850545

The Kuopio Lutetium-177 Study is a clinical trial aimed at understanding the effectiveness and safety of a treatment called 177LuPSMA-I&T for men with advanced prostate cancer that has spread to ot...

Recruiting

Type: observational Locations: Kuopio, North Savo, Finland

Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) with Advanced Prostate Cancer (CaP)

NCT ID: NCT06470750

This clinical trial is looking at a new approach to cancer care called patient-centered home care (PCHC) to see if it can help improve the health and quality of life for Black men with advanced pro...

Recruiting

Type: observational Locations: Jacksonville, Florida, United States

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

NCT ID: NCT04734730

This clinical trial is looking at a new treatment approach for men with castration-sensitive prostate cancer, which is cancer that still responds to hormone therapy. Researchers are studying the co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

NCT ID: NCT06145633

This clinical trial is studying a new treatment approach for men with a specific type of advanced prostate cancer called PSMA-low metastatic castration-resistant prostate cancer (mCRPC). The trial ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations

NCT ID: NCT05689021

This clinical trial is studying a new treatment combination for men with advanced prostate cancer that no longer responds to hormone therapy and has spread to other parts of the body, particularly ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

Measuring Oncological Value of Exercise and Statin

NCT ID: NCT05796973

This clinical trial is looking at how exercise and a medication called atorvastatin might help improve cancer treatment for patients with advanced cancers like breast, kidney, ovarian, and prostate...

Recruiting

Phase: PHASE3 Type: interventional Locations: Tampere, , Finland, Tampere, Länsi Suomi, Finland

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

NCT ID: NCT05054296

This clinical trial is looking at how a special exercise program and using a Fitbit to track activity can help prostate cancer patients manage their heart health and a condition called metabolic sy...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions